SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001091818-22-000097
Filing Date
2022-07-27
Accepted
2022-07-27 11:54:44
Documents
35
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 QTR. REPORT - JUNE 30, 2022 bfnh-20220630.htm   iXBRL 10-Q 228134
2 CERTIFICATION ex311.htm EX-31.1 4753
3 CERTIFICATION ex312.htm EX-31.2 4949
4 CERTIFICATION ex321.htm EX-32.1 2019
5 CERTIFICATION ex322.htm EX-32.2 1924
11 bfnhlogo2019001.jpg GRAPHIC 27243
  Complete submission text file 0001091818-22-000097.txt   1440401

Data Files

Seq Description Document Type Size
6 bfnh-20220630.xsd EX-101.SCH 23510
7 bfnh-20220630_cal.xml EX-101.CAL 13252
8 bfnh-20220630_def.xml EX-101.DEF 62033
9 bfnh-20220630_lab.xml EX-101.LAB 173445
10 bfnh-20220630_pre.xml EX-101.PRE 67518
29 EXTRACTED XBRL INSTANCE DOCUMENT bfnh-20220630_htm.xml XML 64351
Mailing Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454
Business Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454 757-306-6090
BIOFORCE NANOSCIENCES HOLDINGS, INC. (Filer) CIK: 0001310488 (see all company filings)

IRS No.: 852138858 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51074 | Film No.: 221109984
SIC: 3826 Laboratory Analytical Instruments